|
Kachexie bei Krebs 57 Arzneien acon. alet. alf. alum. ars. ars-i. aur-m-n. bar-c. cadm-met. cadm-s. calc. carb-an. carb-v. carc. card-m. caust. con. cory. cund. ferr-act. ferr-pic. graph. hecla. helon. hydr. iod. kali-bi. kali-chl. kali-cy. kali-i. kali-p. kreos. laur. lev. lob-e. lyc. mez. nat-m. nit-ac. orni. ph-ac. phos. phyt. pic-ac. plac. rad-br. sed-ac. sed-r. semp. sep. sil. silphu. sulph. thuj. turm-chr. trif-p. uran-met. keine Fälle=ein- >1-2 Fälle=zwei- >2 Fälle=Drei- >5 Fälle=Vier- >10 Fälle=FÜNF-wertig ()=BegleitTherapie *=palliativ **=TeilWirkung ***=1-Jahr ****5-Jahre-Nachbeobachtung Complete-Nachträge |
| ^ | acon | Schmidt, CR |
| ^ | alet | Ghegas, CR |
| ^ | alf | Muttathukunnel, CR |
| ^ | alum | bg2 |
| ^ | ars | Bönninghausen, CR |
| ^ | ars-i | CR |
| ^ | aur-m-n | Spinedi, CR |
| ^ | bar-c | bg2 |
| ^ | cadm-met | Grimmer, CR |
| ^ | cadm-s | mp |
| ^ | calc | bg2 |
| ^ | carb-an | sne, Boericke, CR |
| ^ | carb-v | bg2 |
| ^ | carc | Boericke, CR |
| ^ | card-m | sne |
| ^ | caust | bg2 |
| ^ | con | bg2 |
| ^ | cory | jne1, br1 |
| ^ | cund | bg2, sne |
| ^ | ferr-act | bn11 |
| ^ | ferr-pic | Jus |
| ^ | graph | bg2 |
| ^ | hecla | sne |
| ^ | helon | Ghegas, CR |
| ^ | hydr | br, bg2, kr1, MMPP |
| ^ | iod | bg2 |
| ^ | kali-bi | Clarke, CR |
| ^ | kali-chl | bg2 |
| ^ | kali-cy | Tyrell, CR |
| ^ | kali-i | bg2 |
| ^ | kali-p | Clarke, CR |
| ^ | kreos | bg2 |
| ^ | laur | Clarke, CR |
| ^ | lev | sgx |
| ^ | lob-e | sne |
| ^ | lyc | bg2 |
| ^ | mez | Muttathukunnel, CR |
| ^ | nat-m | CR |
| ^ | nit-ac | bg2 |
| ^ | orni | sne |
| ^ | ph-ac | Ghegas, CR |
| ^ | phos | gm? |
| ^ | phyt | bg2 |
| ^ | pic-ac | c1 |
| ^ | plac | Eberle, CR |
| ^ | rad-br | bg2 |
| ^ | sed-ac | gm2 |
| ^ | sed-r | sgx |
| ^ | semp | sne |
| ^ | sep | Muttathukunnel, CR |
| ^ | sil | bg2 |
| ^ | silphu | Clarke, CR |
| ^ | sulph | bg2 |
| ^ | thuj | k2, bg2 |
| ^ | turm-chr | Schadde, CR |
| ^ | trif-p | gm2 |
| ^ | uran-met | Eberle, CR |